Corton Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-62,491
| Closed | -$412K | – | 602 |
|
|
2024
Q3 | $412K | Buy |
62,491
+48,399
| +343% | +$319K | 0.2% | 95 |
|
|
2024
Q2 | $106K | Buy |
+14,092
| New | +$106K | 0.06% | 450 |
|
|
2023
Q3 | – | Sell |
-19,801
| Closed | -$148K | – | 523 |
|
|
2023
Q2 | $148K | Sell |
19,801
-12,860
| -39% | -$96.1K | 0.07% | 365 |
|
|
2023
Q1 | $218K | Buy |
+32,661
| New | +$218K | 0.15% | 219 |
|
|
2022
Q3 | – | Sell |
-16,598
| Closed | -$135K | – | 357 |
|
|
2022
Q2 | $135K | Buy |
+16,598
| New | +$135K | 0.13% | 261 |
|